ʻO Yerba Mate

Anter

• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

He mea kanu ʻo Yerba mate. Hoʻohana ʻia ka lau i lāʻau.

Lawe kekahi poʻe i ka hoa wahine ma ka waha e hōʻoluʻolu i ka luhi o ka noʻonoʻo a me ke kino (luhi), a me ka maʻi luhi mau loa (CFS). Lawe ʻia hoʻi e ka waha no nā hoʻopiʻi e pili ana i ka puʻuwai e like me ka maikaʻi ʻole o ka puʻuwai, ka puʻuwai maikaʻi ʻole, a me ke kahe o ke koko haʻahaʻa.

Lawe pū kekahi poʻe i ka hoa wahine yerba e ka waha e hoʻomaikaʻi ai i ke ʻano a me ke kaumaha; no ka maʻi kō; kiʻekiʻe kolesterol; iwi iwi nāwaliwali (osteoporosis); e hoʻomaha ai i ka ʻeha poʻo a me nā ʻeha pū; e mālama i nā maʻi maʻi urinary tract (UTIs), a me nā pūpū a me nā pōhaku ʻino; no ka pohō kaumaha; a ma ke ʻano he laxative.

I nā meaʻai, hoʻohana ʻia ʻo yerba mate e hana i kahi mea inu kī.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no MATE YERBA penei:

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• Hana Athletic. Hōʻike kahi noiʻi mua i hoʻokahi mahele o ka hoa wahine ma mua o ka hoʻoikaika kino e hōʻemi paha i ka pōloli ma mua o ka hoʻomaʻamaʻa a hoʻomaikaʻi i ke ʻano ma hope o ka hoʻoikaika ʻana i nā wahine. Hōʻike kekahi mau noiʻi ʻē aʻe i ka lawe ʻana i ka ipo yerba i kēlā me kēia lā no 5 mau lā e hoʻomaikaʻi kūpono paha i ka hana hoʻoikaika kino i nā mea haʻuki hoʻomaʻamaʻa.
• Nā mākau hoʻomanaʻo a me ka noʻonoʻo (function cognitive). Hōʻike ka noiʻi mua ʻana i ka inu ʻana i ka mea inu me ka hoa wahine yerba ʻaʻole ia e hoʻomaikaʻi i ka hoʻomanaʻo ʻana, ka manawa hopena, a me ka noʻonoʻo pono i nā wahine maikaʻi.
• Diabetes. Hōʻike ka noiʻi mua i ka inu ʻana i ka tī yerba mate ʻekolu mau manawa i kēlā me kēia lā no 60 mau lā hiki ke hoʻohaʻahaʻa i ke kō i ke kō i ka poʻe me ka maʻi diabetes type 2.
• Nā pae kiʻekiʻe o ke kolesterol a i ʻole nā ​​momona ʻē aʻe (lipids) i ke koko (hyperlipidemia). Hōʻike ka noiʻi mua ʻana i ka inu ʻana i ka tī me ka mate yerba ʻekolu manawa i kēlā me kēia lā no 40 mau lā hiki ke hoʻohaʻahaʻa i ka nui o ke kolukol a me ka lipoprotein haʻahaʻa (LDL a i ʻole "maikaʻi") kolesterol, a hoʻonui i ka lipoprotein (HDL a i ʻole "maikaʻi") kolesterol, i ka poʻe me ke kōpaʻa kiʻekiʻe. Hoʻopili kēia i nā poʻe e lawe nei i nā lāʻau statin. Eia nō naʻe, hōʻike ʻia kahi noiʻi ʻē aʻe ʻaʻole hiki ke hoʻololi i ka nui o ka lipid i nā mākua me ka maʻi HIV ʻole.
• Ka momona. Hōʻike ka noiʻi mua i ka lawe ʻana i ka ipo yerba e ka waha e hoʻoliʻiliʻi paha i ka momona a hana i ka pohō kaumaha ke hoʻohana wale ʻia a i ʻole ka hui pū ʻana me ka guarana a me ka damiana.
• Nā iwi palupalu a palupalu (osteoporosis). ʻO ka inu ʻana i ka tī yerba mate i kēlā me kēia lā no ka liʻiliʻi o 4 mau makahiki e hōʻemi paha i ka helu o ka nalo ʻana o ka iwi i nā wahine postmenopausal. Eia nō naʻe, hōʻike ʻia kahi noiʻi ʻē aʻe ʻaʻole paha he hopena o ka yerba mate ma ka helu o ka nalo ʻana o ka iwi i nā wahine postmenopausal.
• Prediabetes. Hōʻike ka noiʻi mua i ka inu ʻana i ka tii mate ʻekolu mau manawa i kēlā me kēia lā no 60 mau lā ʻaʻole e hōʻemi i ka hoʻokēʻai ʻana i ke kō i ka poʻe me ka prediabetes. Eia naʻe, hoʻemi paha ia i ka hemoglobin glycated (HbA1C), kahi ana o ke kō kō kō awelika.
• Maʻi luhi syndrome (CFS).
• Konipōpō.
• Kaumaha.
• Poʻo poʻo poʻo.
• Nā kūlana puʻuwai.
• Pōhaku hakuʻala a me ka ʻai.
• Kaomi haʻahaʻa.
• Nā maʻi maʻi urinary (UTIs).
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i ka pono o yerba mate no kēia mau hoʻohana.

Aia i loko o ka hoa ʻo Yerba ka caffeine a me nā kemika ʻē aʻe e hoʻoulu ai i ka lolo, ka puʻuwai, nāʻiʻo e uhi ana i nā kīʻaha koko, a me nā ʻāpana ʻē aʻe o ke kino. Ke lawe ʻia e ka waha:ʻO Yerba mate ʻo SAFE MAU PONO no ka hapa nui o ka poʻe ke lawe ʻia no nā wā pōkole. Aia ka Yerba mate i ka caffeine, i hiki i kekahi poʻe ke kumu i nā hopena ʻē aʻe e like me ka hiki ʻole ke hiamoe (hiamoe), ka makaʻu a me ka hoʻomaha ʻole, ka ʻōpū huhū, ka pīhoihoi a me ka luaʻi, hoʻonui ʻia ka helu o ka puʻuwai a me ka hanu ʻana, a me nā hopena ʻē aʻe.

ʻO Yerba mate ʻo POSSIBLY UNSAFE ke lawe ʻia i ka nui a i ʻole no nā wā lōʻihi. ʻO ka ʻai ʻana i ka nui o ka hoa hoa yerba (ʻoi aku ma mua o 12 kīʻaha i kēlā me kēia lā) hiki ke hōʻeha i ka maʻi poʻo, ka hopohopo, ka hoʻonāukiuki, ke kani ʻana i nā pepeiao, a me nā puʻuwai puʻuwai ʻole. ʻO ka inu ʻana i ka nui o yerba mate (1-2 liters i kēlā me kēia lā) hoʻonui pū i ka makaʻu o ka maʻi ʻaʻai esophageal, maʻi ʻaʻai puʻuwai, ʻōpū o ka ʻōpū, maʻi ʻaʻai maʻi hānai, maʻi ʻaʻai maʻi hānai, maʻi ʻaʻai prostate, maʻi ʻaʻā māmā, a me ka maʻi ʻaʻai laryngeal a waha paha. ʻOi aku ke kiʻekiʻe o kēia makaʻāinana no ka poʻe puhipaka a inu waiʻona paha.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻO Yerba hoa wahine ʻo POSSIBLY UNSAFE ke lawe ʻia e ka waha i ka wā hāpai. ʻO kekahi hopohopo ka hoʻohana ʻana i ka hoa yerba me he mea lā e hoʻonui i ka makaʻu o ka loaʻa ʻana i ka maʻi ʻaʻai. ʻAʻole maopopo inā lawe ʻia kēlā pilikia i ka fetus e ulu nei. ʻO kekahi hopohopo ka ʻikepili caffeine o yerba mate. Keʻa nei ʻo Caffeine i ka placenta a komo i ke kahena o ke fetus, e hana ana i nā pae o ka caffeine i loko o ka pēpē e like me ka pae caffeine i ka makuahine. I ka laulā, pono i nā makuahine ke hōʻalo i ka ʻai ʻana ma mua o 300 mg o ka caffeine i kēlā me kēia lā; aia ma kahi o 6 mau kīʻaha o ka hoa kāne yerba. Hānau ʻia nā pēpē i nā makuahine e hoʻopau i ka nui o ka caffeine i ka wā hāpai i kekahi manawa hōʻike i nā ʻōuli o ka haʻalele ʻana o ka caffeine ma hope o ka hānau ʻana. Ua hoʻopili pū ʻia nā kaha kiʻekiʻe o ka caffeine me ka hāʻule ʻole o ka hānau, lawe wā ʻōpio, a me ke kaumaha o ka hānau haʻahaʻa. Eia nō naʻe, ua aʻo nā kānaka noiʻi i nā makuahine i inu i ka ti yerba mate i ka wā hāpai a ʻike ʻole i ka pilina ikaika ma waena o ka inu ʻana i ka hoa kāne a me ka hānau manawa a i ʻole ka hānau hānau liʻiliʻi. Akā ua hoʻopiʻi ʻia kēia aʻo ʻana no ka mea ʻaʻole ia i noʻonoʻo i ka nui o ka yerba mate a i ʻole ka caffeine i hoʻohana ʻia e nā makuahine; nānā wale ia i ka manawa hea a lākou e hoʻohana ai i ka hoa kāne.

ʻO Yerba mate kekahi POSSIBLY UNSAFE i ka wā hānai umauma. ʻAʻole i ʻike ʻia inā komo ka kemikena i loko o yerba mate i loko o ka waiū o ka waiū, akā he hopohopo kēlā. He pilikia pū ka caffeine ma yerba mate. Hiki ke hoʻonāukiuki a hoʻonui i ka neʻe ʻana o ka ʻōpū i nā pēpē hānai.

Nā keiki: ʻO Yerba hoa kāne ʻo POSSIBLY UNSAFE no nā keiki ke lawe ʻia e ka waha. Pili ʻo Yerba mate me ka hoʻonui ʻia o ka makaʻu o ka maʻi ʻaʻai esophageal, maʻi ʻaʻai pūpū, maʻi ʻaʻai ʻōpū, maʻi ʻaʻai pūhū, maʻi ʻaʻa ʻohana, maʻi ʻaʻai prostate, maʻi ʻaʻai māmā, a me ka maʻi ʻaʻai laryngeal a waha paha.

ʻAlekohola: Hoʻohana ka waiʻona nui me ka hoʻohana wā lōʻihi ʻo yerba mate e hoʻonui ai i ka makaʻu o ke kanesa mai ka 3-fold a i ka 7-fold.

Nā pilikia kūpilikiʻi: ʻO ka caffeine ma yerba mate e hoʻonui i nā maʻi pīhoihoi.

Nā maʻi hōʻeha: Hoʻowīwī paha ʻo Caffeine i ke kāpili ʻana. A ʻo kahi hopena, aia kekahi hopohopo e ʻoi aku paha ka maikaʻi o ka caffeine i ka hoa wahine yerba. Akā i kēia manawa, ʻaʻole i hōʻike ʻia kēia hopena i ka poʻe.

Nā kūlana puʻuwai: ʻO ka caffeine i ka hoa yerba hiki ke hana i nā puʻuwai kūlike ʻole i kekahi mau kānaka. Inā loaʻa ʻoe i kahi maʻi puʻuwai, e kūkākūkā e hoʻohana ana i ka yerba mate me kāu kauka.

Diabetes: Ke hōʻike nei kekahi mau noiʻi e hiki i ka caffeine ma ka wahine yerba ke hoʻololi i ke ala o ka poʻe me ka maʻi kō i ke kō a hiki ke hoʻopilikia i ka kaohi kō kō. Aia kekahi mau noiʻi hoihoi e hōʻike ana i ka caffeine e hana i nā hōʻailona hōʻailona o ke kō kō i lalo i nā poʻe me ka maʻi diabetes 1. Hōʻike kekahi mau noiʻi e ʻoi aku ka ikaika o nā ʻōuli o ke kō kō ke kō i ko lākou hoʻomaka ʻana i ka puka ʻole o ka caffeine, akā ke hoʻomau mau nei ke kō kō, haʻahaʻa nā ʻōuli me ka caffeine. E hoʻonui paha kēia i ka hiki i ka poʻe me ka maʻi diabetes ke ʻike a mālama i ke kō kō. Eia nō naʻe, ʻo ka mea ʻāpiki e hoʻonui paha ka caffeine i ka helu o nā kō kō haʻahaʻa. Inā loaʻa ʻoe i ka maʻi diabetes, e kamaʻilio me kāu kauka olakino ma mua o ka hoʻohana ʻana i ka hoa wahine.

Pohā: Loaʻa ka caffeine iā Yerba mate. ʻO ka caffeine i ka hoa wahine, ʻoiai ke lawe ʻia i ka nui, hiki ke hōʻino i ka palahī.

Glaucoma: Hoʻohana ka yerba mate i ke kaomi i loko o ka maka ma muli o ka caffeine i loaʻa. Hoʻonui ka piʻi o ke kaomi i loko o 30 mau minuke a mau no 90 mau minuke. Inā loaʻa iā ʻoe ka glaucoma, e kūkākūkā i kāu hoʻohana ʻana i ka hoa yerba me kāu kauka olakino.

Piʻi koko kiʻekiʻe: Loaʻa ka caffeine iā Yerba mate. ʻO ka inu ʻana i ka caffeine e hoʻonui ai i ke koko i ka poʻe me ke koko kiʻekiʻe. Eia nō naʻe, emi paha kēia hopena i ka poʻe inu mau i ka caffeine mau.

ʻO ka maʻi huhū huhū (IBS): Loaʻa ka caffeine iā Yerba mate. ʻO ka caffeine i ka hoa kāne yerba, keu hoʻi i ka lawe ʻia i ka nui, hiki ke hōʻino i ka maʻi pākī a hōʻeha paha i nā ʻōuli o IBS.

Nā iwi nāwaliwali (osteoporosis): Ua ʻike kekahi mau kānaka noiʻi i nā wahine postmenopausal e inu i nā kīʻaha 4 a ʻoi aku paha o kēlā me kēia lā o ke kīʻaha yerba mate ʻAmelika Hema i ʻoi aku ka kiʻekiʻe o ka iwi. Akā hōʻike ʻia kahi noiʻi ʻē aʻe i ka ʻole o ka hopena o ka hoa yerba ma nā iwi o nā wahine postmenopausal. Eia kekahi, ʻo ka caffeine i loko o ka hoa yerba ka mea e hoʻomālamalama i ka calcium mai ke kino i ka mimi. Hiki i kēia ke kōkua i nā iwi nāwaliwali. Inā loaʻa iā ʻoe ka osteoporosis, e kaupalena i ka ʻai ʻana o ka caffeine ma lalo o 300 mg i kēlā me kēia lā (ma kahi o 6 mau kīʻaha o ka hoa wahine yerba). Hiki ke kōkua i ka lawe ʻana i ke kalima keu no ka hoʻopiha ʻana i ka puna. Inā ʻoe olakino maʻamau a loaʻa ka lawa ʻana o ka calcium mai kāu meaʻai a me nā mea hoʻopihapiha, lawe a 400 mg o ka caffeine i kēlā me kēia lā (ma kahi o 8-10 kīʻaha o ka hoa yerba) ʻaʻole ia e hoʻonui i ka makaʻu o ka loaʻa ʻana o ka osteoporosis. ʻO nā wahine Postmenopausal i loaʻa kahi ʻano hoʻoilina e mālama iā lākou mai ka hana ʻana i ka wikamina D maʻamau, e akahele loa i ka hoʻohana ʻana i ka caffeine.

Aia kekahi mau wahine i ka makaʻu kūikawā i nā iwi nāwaliwali. He kūlana hoʻoilina kēia mau wahine i mea paʻakikī iā lākou e hoʻohana kūpono i ka wikamina D. Hana ka Vitamin D me ka calcium e kūkulu i nā iwi ikaika. Pono e akahele pono kēia mau wahine e kaohi i ka nui o nā caffeine a lākou e loaʻa ai mai ka hoa yerba a me nā kumuwaiwai ʻē aʻe.

Puhipaka: ʻO ka makaʻu o ka loaʻa ʻana i ka maʻi ʻaʻai he 3 a 7 mau manawa ke kiʻekiʻe aʻe i ka poʻe puhipaka a hoʻohana i ka hoa yerba no nā manawa lōʻihi.

Mekia

Mai lawe i kēia hui ʻana.

Nā Amphetamines

ʻO nā lāʻau hōʻeuʻeu e like me nā amphetamines e holo wikiwiki ai i ka ʻōnaehana mānoanoa. Ma ka wikiwiki ʻana i ka ʻōnaehana makaʻu, hiki i nā lāʻau stimulant ke hōʻoluʻolu iā ʻoe a hoʻonui i ka helu o kou puʻuwai. ʻO ka caffeine paha ma yerba mate paha e wikiwiki ai i ka ʻōnaehana nūhou. Lawe i ka hoa wahine yerba me nā lāʻau stimulant i kumu e pilikia i nā pilikia e like me ka hoʻonui ʻana o ka puʻuwai a me ke kiʻekiʻe o ke koko. Hōʻalo i ka lawe ʻana i nā lāʻau stimulant me ka hoa kāne.

ʻO Cocaine

ʻO nā lāʻau hōʻeuʻeu e like me ka cocaine e hoʻōla i ka ʻōnaehana. Ma ka wikiwiki ʻana i ka ʻōnaehana, hiki i nā lāʻau stimulant ke hōʻoluʻolu iā ʻoe a hoʻonui i ka helu o kou puʻuwai. ʻO ka caffeine paha ma yerba mate paha e wikiwiki ai i ka ʻōnaehana nūhou. Lawe i ka hoa wahine yerba me nā lāʻau stimulant i kumu e pilikia i nā pilikia e like me ka hoʻonui ʻana o ka puʻuwai a me ke kiʻekiʻe o ke koko. Hōʻalo i ka lawe ʻana i nā lāʻau stimulant me ka hoa kāne.

Ephedrine

Hoʻoikaika ka lāʻau lapaʻau stimulant i ka ʻōnaehana hopohopo. ʻO Caffeine (i loko o ka yerba mate) a me ka ephedrine nā lāʻau stimulant ʻelua. ʻO ka lawe ʻana i ka caffeine me ka ephedrine paha ke kumu o ka hoʻonāukiuki nui ʻana a i kekahi manawa nui nā hopena ʻaoʻao a me nā pilikia puʻuwai. Mai lawe i nā huahana i loaʻa i ka caffeine a me ka ephedrine i ka manawa like.

Kānāwai

E akahele me kēia hui ʻana.

Adenosine (Adenocard)

Loaʻa ka caffeine iā Yerba mate. Hiki paha i ka caffeine i ka hoa yerba ke ālai i nā hopena o adenosine (Adenocard). Hoʻohana pinepine ʻia ʻo Adenosine (Adenocard) e nā kauka e hana i kahi hōʻike ma ka puʻuwai. Kapa ʻia kēia hōʻike he hoʻāʻo koʻikoʻi puʻuwai. E hoʻōki i ka ʻai ʻana i ka hoa kāne yerba a i ʻole nā ​​huahana i loaʻa i ka caffeine ma ka liʻiliʻi he 24 mau hola ma mua o ka hoʻāʻo ʻana o ka naʻau koʻikoʻi.

Nā Antibiotics (antibiotic Quinolone)

Loaʻa ka caffeine iā Yerba mate. Hōʻoki ke kino i ka caffeine ma yerba mate e kāpae iā ia. Hiki i kekahi mau antibiotic ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana i kēia mau lāʻau me ka caffeine e hoʻonui ai i ka hopena o nā hopena ʻē aʻe e like me ka jitteriness, headache, hoʻonui ka puʻuwai puʻuwai, a me nā mea ʻē aʻe.

ʻO kekahi mau lāʻau ʻino e hoʻemi i ka wikiwiki o ke kino e haki i ka caffeine e komo pū ana me ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), ofloxacin (Floxin), a me nā mea ʻē aʻe.

Carbamazepine (Tegretol)

ʻO Carbamazepine kahi lāʻau i hoʻohana ʻia e mālama i ka hopu ʻana. Hiki i ka cafe ke hōʻemi i nā hopena o ka carbamazepine. Ma muli o ka yerba mate i loko o ka caffeine, i ke kumumanaʻo lawe i ka yerba mate me ka carbamazepine e hoʻoliʻiliʻi paha i nā hopena o ka carbamazepine a hoʻonui i ka maka o ka hopu ʻana i kekahi poʻe.

Cimetidine (Tagamet)

Loaʻa ka caffeine iā Yerba mate. Hōʻoki ke kino i ka caffeine e kāpae iā ia. Hiki i ka Cimetidine (Tagamet) ke hoʻēmi i ka wikiwiki o kou kino e wāwahi i ka caffeine. Lawe i ka cimetidine (Tagamet) me ka hoa wahine ʻo yerba paha e hoʻonui i ka manawa o nā hopena caffeine e like me ka jitteriness, headache, heartbeat wikiwiki, a me nā mea ʻē aʻe.

ʻO Clozapine (Clozaril)

Haki ke kino i ka clozapine (Clozaril) e hemo ai. ʻO ka caffeine ma yerba mate me he mea lā e hōʻemi ana i ka wikiwiki o ke kino e wāwahi i ka clozapine (Clozaril). Lawe i ka hoa wahine yerba me ka clozapine (Clozaril) hiki ke hoʻonui i nā hopena a me nā hopena ʻē aʻe o clozapine (Clozaril).

Dipyridamole (Persantine)

Loaʻa ka caffeine iā Yerba mate. Hiki paha i ka caffeine ma ka hoa yerba ke ālai i nā hopena o dipyridamole (Persantine). Hoʻohana pinepine ʻia ʻo Dipyridamole (Persantine) e nā kauka e hana i kahi hōʻike ma ka puʻuwai. Kapa ʻia kēia hōʻike he hoʻāʻo koʻikoʻi puʻuwai. E hoʻōki i ka ʻai ʻana i ka hoa kāne yerba a i ʻole nā ​​huahana ʻē aʻe i loaʻa i ka caffeine ma ka liʻiliʻi he 24 mau hola ma mua o ka hoʻāʻo ʻana o ka naʻau koʻikoʻi.

ʻO Disulfiram (Antabuse)

Hōʻoki ke kino i ka caffeine e kāpae iā ia. Hiki i ka Disulfiram (Antabuse) ke hōʻemi i ka wikiwiki o ke kino e hoʻopau i ka caffeine. Lawe i ka mate yerba (kahi i loaʻa ka caffeine) me disulfiram (Antabuse) e hoʻonui i nā hopena a me nā hopena ʻē aʻe o ka caffeine e like me ka jitteriness, hyperactivity, hoʻonāukiuki, a me nā mea ʻē aʻe.

ʻO Estrogens

Hōʻoki ke kino i ka caffeine (i loko o ka yerba mate) e hoʻopau iā ia. Hiki i nā Estrogens ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka hōʻemi ʻana i ka haki ʻana o ka caffeine hiki ke kumu i ka jitteriness, ka maʻi poʻo, ka puʻuwai wikiwiki, a me nā hopena ʻē aʻe. Inā lawe ʻoe i estrogens, e kaupalena i kāu lawe ʻana i ka caffeine.

ʻO kekahi o nā pila estrogen me nā conjugated equine estrogens (Premarin), ethinyl estradiol, estradiol, a me nā mea ʻē aʻe.

Ethosuximide (Zarontin)

ʻO Ethosuximide kahi lāʻau i hoʻohana ʻia e mālama i ka hopu ʻana. Hiki i ka cafeeine i ka hoa yerba ke hoʻēmi i nā hopena o ka ethosuximide. ʻO ka lawe ʻana i ka hoa yerba me ka ethosuximide e hoʻoliʻiliʻi paha i nā hopena o ka ethosuximide a hoʻonui i ka hopena o ka hopu ʻana i kekahi mau kānaka.

Felbamate (Felbatol)

ʻO Felbamate kahi lāʻau i hoʻohana ʻia e mālama i ka hopu ʻana i ka maʻi. ʻO ka cafeeine ma yerba mate e hōʻemi paha i nā hopena o felbamate. ʻO ka lawe ʻana i ka ipo yerba me ka felbamate e hōʻemi paha i nā hopena o felbamate a hoʻonui i ka hopena o ka hopu ʻana i kekahi mau kānaka.

Flutamide (Eulexin)

Haki ke kino i ka flutamide (Eulexin) e kāpae iā ia. Hiki i ka cafeeine i ka wahine yerba ke hoʻemi i ka wikiwiki o ke kino e hoʻopau i ka flutamide. Hiki i kēia ke waiho i ka flutamide e noho lōʻihi i ke kino a hoʻonui i ka hopena o nā hopena ʻaoʻao.

Fluvoxamine (Luvox)

Hōʻoki ke kino i ka caffeine ma yerba mate e kāpae iā ia. Hiki i ka Fluvoxamine (Luvox) ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka caffeine. Lawe i ka hoa wahine yerba me fluvoxamine (Luvox) paha e kumu i ka nui o ka caffeine i loko o ke kino, a hoʻonui i nā hopena a me nā hopena ʻē aʻe o yerba mate.

Likiuma

Lawe maoli kou kino i ka lithium. Hiki i ka caffeine i ka hoa yerba ke hoʻonui i ka wikiwiki o ka hoʻopau ʻana o kou kino i ka lithium. Inā lawe ʻoe i nā huahana i loaʻa ka caffeine a lawe ʻoe i ka lithium, e hoʻōki mālie i ka lawe ʻana i nā huahana caffeine. ʻO ka kū koke ʻana i ka hoa wahine hiki ke hoʻonui i nā hopena o ka lithium.

Nā lāʻau no ka hānō (Beta-adrenergic agonists)

Loaʻa ka caffeine iā Yerba mate. Hiki i ka cafeeine ke hoʻoulu i ka naʻau. Hiki i kekahi mau lāʻau no ka hānō ke hoʻoulu i ka puʻuwai. Lawe i ka caffeine me kekahi mau lāʻau no ka hānō e hoʻonāukiuki paha i ka nui a hoʻonā i nā pilikia o ka puʻuwai.

ʻO kekahi mau lāʻau no ka hānō e pili pū me ka albuterol (Proventil, Ventolin, Volmax), metaproterenol (Alupent), terbutaline (Bricanyl, Brethine), isoproterenol (Isuprel), a me nā mea ʻē aʻe.

Nā lāʻau no ke kaumaha (MAOI)

Hiki i ka caffeine i ka hoa yerba ke hoʻonāukiuki i ke kino. Hiki i kekahi mau lāʻau i hoʻohana ʻia no ke kaumaha ke hoʻoulu i ke kino. ʻO ka inu ʻana i ka hoa kāne a me ka lawe ʻana i kekahi mau lāʻau no ke kaumaha e hoʻonāukiuki paha i ke kino a me nā hopena ʻē aʻe e like me ka wikiwiki o ka puʻuwai, ke koko kiʻekiʻe, ka makaʻu, a me nā mea ʻē aʻe i kū.

ʻO kekahi o kēia mau lāʻau i hoʻohana ʻia no ke kaumaha e komo pū me rasagiline (Azilect), selegiline (Eldepryl, Zelapar), tranylcypromine (Parnate), phenelzine (Nardil), a me nā mea ʻē aʻe.

Nā lāʻau i hoʻolohi i ke kō ʻana o ke koko (Anticoagulant / Antiplatelet drug)

Loaʻa ka caffeine iā Yerba mate. Hiki i ka cafe ke hoʻolohi i ke kō ʻana o ke koko. Lawe i ka hoa wahine yerba me nā lāʻau lapaʻau e hōʻemi ana i ka hoʻopili ʻana e hoʻonui i nā manawa o ka palapū a me ke kahe ʻana o ke kahe.

ʻO kekahi mau lāʻau e lohi ai ke kāpili ʻana o ke koko me aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, a me nā mea ʻē aʻe), ibuprofen (Advil, Motrin, a me nā mea ʻē aʻe), naproxen (Anaprox, Naprosyn, a me nā mea ʻē aʻe), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), a me nā mea ʻē aʻe.

Nikotine

ʻO nā lāʻau hōʻeuʻeu e like me ka nikotine e hoʻolalelale i ka ʻōnaehana. Ma ka wikiwiki ʻana i ka ʻōnaehana, hiki i nā lāʻau stimulant ke hōʻoluʻolu iā ʻoe a hoʻonui i ka helu o kou puʻuwai. ʻO ka caffeine paha ma yerba mate paha e wikiwiki ai ka ʻōnaehana ʻōnaehana. Lawe i ka hoa wahine yerba me nā lāʻau stimulant i kumu e pilikia i nā pilikia e like me ka hoʻonui ʻana o ka puʻuwai a me ke kiʻekiʻe o ke koko. Hōʻalo i ka lawe ʻana i nā lāʻau stimulant me ka hoa kāne.

Pentobarbital (Nembutal)

Hiki i nā hopena stimulant o ka caffeine i yerba mate ke pale i nā hopena hana hiamoe o pentobarbital.

Phenobarbital (Luminal)

ʻO Phenobarbital kahi lāʻau i hoʻohana ʻia e mālama i ka hopu ʻana. Hiki i ka cafeeine i ka hoa wahine yerba ke hoʻoliʻiliʻi i nā hopena o phenobarbital a hoʻonui i ka hopena o ka hopu ʻana i kekahi mau kānaka.

Phenylpropanolamine

Loaʻa ka caffeine iā Yerba mate. Hiki i ka cafeeine ke hoʻoulu i ke kino. Hiki i ka Phenylpropanolamine ke hoʻoulu i ke kino. Lawe pū ʻia ʻo yerba mate a me phenylpropanolamine paha e hoʻonāukiuki i ka nui a hoʻonui i ka puʻuwai a me ke kahe o ke koko a hoʻonāukiuki.

Phenytoin (Dilantin)

ʻO Phenytoin kahi lāʻau i hoʻohana ʻia e mālama i ka hopu ʻana. Hiki i ka cafeeine i ka hoa yerba ke hōʻemi i nā hopena o ka phenytoin. ʻO ka lawe ʻana i ka ipo yerba me phenytoin e hōʻemi paha i nā hopena o phenytoin a hoʻonui i ka hopena o ka hopu ʻana i kekahi poʻe.

Riluzole (Rilutek)

Haki ke kino i ka riluzole (Rilutek) e hemo ai. Lawe ka yerba mate i hiki ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka riluzole (Rilutek) a hoʻonui i nā hopena a me nā hopena ʻē aʻe o riluzole.

Nā lāʻau lapaʻau hōʻoluʻolu (Benzodiazepines)

ʻO Benzodiazepines nā lāʻau i hiki ke hiamoe a hiamoe. Haki ke kino i nā benzodiazepines e kipaku iā lākou. Hiki i ka caffeine ma ka hoa yerba ke hoʻemi i ka haki o nā benzodiazepines. Hoʻonui paha kēia i nā hopena o benzodiazepines a hana i ka hiamoe nui. Mai hoʻohana i ka wahine yerba inā ʻoe e lawe benzodiazepines.

Aia kekahi mau benzodiazepine me alprazolam (Xanax), clonazepam (Klonopin), diazepam (Valium), lorazepam (Ativan), a me nā mea ʻē aʻe.

Nā lāʻau hoʻāla

Hoʻoikaika ka lāʻau lapaʻau stimulant i ka ʻōnaehana hopohopo. Ma ka wikiwiki ʻana i ka ʻōnaehana, hiki i nā lāʻau stimulant ke hoʻohoka iā ʻoe a wikiwiki i kou puʻuwai puʻuwai. Hiki nō hoʻi i ka caffeine i ka hoa wahine yerba ke wikiwiki i ka ʻōnaehana hopohopo. ʻO ka ʻai ʻana i ka hoa kāne yerba a me nā lāʻau stimulant paha ke kumu o nā pilikia koʻikoʻi e like me ka hoʻonui ʻana o ka puʻuwai a me ke kiʻekiʻe o ke koko. Hōʻalo i ka lawe ʻana i nā lāʻau stimulant me ka hoa kāne.

ʻO kekahi mau lāʻau stimulant pū me diethylpropion (Tenuate), epinephrine, nikotine, cocaine, amphetamines, phentermine (Ionamin), pseudoephedrine (Sudafed), a me nā mea ʻē aʻe ʻē aʻe.

ʻO Theophylline

Loaʻa ka caffeine iā Yerba mate. Hana like ka cafe i ka theophylline. Hiki i ka cafe ke hoʻemi i ka wikiwiki o ke kino e hemo i ka theophylline. ʻO ka lawe ʻana i ka hoa wahine yerba me ka theophylline e hoʻonui paha i nā hopena a me nā hopena ʻaoʻao o theophylline.

Valproate

ʻO Valproate kahi lāʻau i hoʻohana ʻia e mālama i ka hopu ʻana. Hiki i ka cafeeine i ka hoa yerba ke hoʻēmi i nā hopena o ka valproate a hoʻonui i ka hopena o ka hopu ʻana i kekahi mau kānaka.

Verapamil (Calan, kekahi)

Hōʻoki ke kino i ka caffeine ma yerba mate e kāpae iā ia. Hiki iā Verapamil (Calan, nā mea ʻē aʻe) ke hoʻēmi i ka wikiwiki o ke kino e hoʻopau i ka caffeine. ʻO ka inu ʻana i ka hoa yerba a me ka lawe ʻana i ka verapamil (Calan, nā poʻe ʻē aʻe) hiki ke hoʻonui i ka hopena o nā hopena ʻaoʻao no ka caffeine e like me ka jitteriness, headache, a me ka hoʻonui ʻana o ka naʻau.

Pila wai (Diuretic lāʻau)

Hiki i ka cafe ke hōʻemi i nā pae potassium. Hiki i nā paila wai ke hoʻemi i nā pae potassium. ʻO ka lawe ʻana i ka ipo yerba me nā wai wai e hoʻonui ai i ka makaʻu o ka hoʻoliʻiliʻi potassium.

ʻO kekahi mau "wai wai" i hiki ke hoʻopau i ka potassium e komo pū me ka chlorothiazide (Diuril), chlorthalidone (Thalitone), furosemide (Lasix), hydrochlorothiazide (HCTZ, HydroDiuril, Microzide), a me nā mea ʻē aʻe.

Mea liʻiliʻi

E makaʻala me kēia hui pū.

ʻAlekohola (Ethanol)

Hōʻoki ke kino i ka caffeine ma yerba mate e kāpae iā ia. Hiki i ka waiʻona ke hoʻemi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana i ka hoa kāne ʻo yerba me ka wai ʻona ka mea e nui ai ka caffeine i ke kahe o ke koko a me nā hopena ʻaoʻao me ka hopena o ka jitteriness, headache, a me ka puʻuwai wikiwiki.

Nā lāʻau hoʻomalu hānau (nā lāʻau lapaʻau Contraceptive)

Hōʻoki ke kino i ka caffeine ma yerba mate e kāpae iā ia. Hiki i nā kaola kaohi hānau ke hōʻemi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana i ka hoa kāne ʻo yerba me nā lāʻau kaohi hānau hiki ke kumu i ka jitteriness, ka maʻi poʻo, ka puʻuwai wikiwiki, a me nā hopena ʻē aʻe.

ʻO kekahi o nā lāʻau kaohi hānau me ethinyl estradiol a me levonorgestrel (Triphasil), ethinyl estradiol a me norethindrone (Ortho-Novum 1/35, Ortho-Novum 7/7/7), a me nā mea ʻē aʻe.

ʻO Fluconazole (Diflucan)

Loaʻa ka caffeine iā Yerba mate. Hōʻoki ke kino i ka caffeine e kāpae iā ia. Hiki i ka Fluconazole (Diflucan) ke hoʻoliʻiliʻi i ka wikiwiki o ka hoʻopau ʻana o ke kino i ka caffeine. ʻO kēia ke kumu o ka noho ʻana o ka caffeine ma ke kino no ka lōʻihi a hoʻonui i ka hopena o nā hopena e like me ka hopohopo, hopohopo, a me ka hiamoe ʻole.

Nā lāʻau no ka maʻi kō (Antidiabetes lāʻau)

Hoʻohana ʻia nā lāʻau diabetes e hoʻohaʻahaʻa i ke kō kō. Loaʻa ka caffeine iā Yerba mate. Wahi a nā hōʻike e hoʻonui a hoʻemi paha ke kō i ke kō. Hoʻopilikia paha ʻo Yerba hoa me ke kaohi kō kō a hoʻoliʻiliʻi i ka maikaʻi o nā lāʻau diabetes. E nānā pono i kāu kō kō. Pono e hoʻololi i ka mahele lāʻau o kāu lāʻau diabetes.

ʻO kekahi mau lāʻau i hoʻohana ʻia no ka maʻi kō me glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), a me kekahi .

ʻO nā lāʻau e hōʻemi ai i ka haki ʻana o nā lāʻau ʻē aʻe e ke akepaʻa (Cytochrome P450 CYP1A2 (CYP1A2) nā mea kūpale)

Loaʻa ka caffeine iā Yerba mate. Uhaʻi ʻia ka cafe ma ke akepaʻa. Hoʻoemi kekahi mau lāʻau i ka maikaʻi o ka haki ʻana o ke ake i nā lāʻau ʻē aʻe. Hiki i kēia mau lāʻau lapaʻau ke hoʻololi i ke akepaʻa ke hoʻemi i ka wikiwiki o ka caffeine i ka wahine yerba i wāwahi ʻia i loko o ke kino. Hoʻonui paha kēia i nā hopena a me nā hopena ʻē aʻe o ka caffeine i ka hoa wahine yerba. ʻO kekahi mau lāʻau e hoʻololi i ke akepaʻa e komo pū me ka cimetidine (Tagamet), fluvoxamine, mexiletine, clozapine, theophylline, a me nā mea ʻē aʻe.

Metformin (Glucophage)

Loaʻa ka caffeine iā Yerba mate. Hōʻoki ke kino i ka caffeine e kāpae iā ia. Hiki i ka Metformin (Glucophage) ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka caffeine. Lawe i ka hoa wahine yerba me ka metformin e kumu i ka nui o ka caffeine i loko o ke kino, a hoʻonui i nā hopena a me nā hopena ʻē aʻe o ka caffeine.

ʻO Methoxsalen (ʻOxsoralen)

Loaʻa ka caffeine iā Yerba mate. Hōʻoki ke kino i ka caffeine e kāpae iā ia. Hiki i ka Methoxsalen (Oxsoralen) ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana i ka caffeine me ka methoxsalen paha ke kumu o ka caffeine i loko o ke kino, a hoʻonui i nā hopena a me nā hopena ʻē aʻe o ka caffeine.

ʻO Mekiletine (Mexitil)

Loaʻa ka caffeine iā Yerba mate. Hōʻoki ke kino i ka caffeine e kāpae iā ia. Hiki i ka Mexiletine (Mexitil) ke hoʻēmi i ka wikiwiki o ke kino e wāwahi i ka caffeine. ʻO ka lawe ʻana iā Mexiletine (Mexitil) me ka hoa yerba e hoʻonui paha i nā hopena caffeine a me nā hopena ʻē aʻe o yerba mate.

Terbinafine (Lamisil)

Hōʻoki ke kino i ka caffeine (i loko o ka yerba mate) e hoʻopau iā ia. Hiki iā Terbinafine (Lamisil) ke hoʻēmi i ka wikiwiki o ke kino e hoʻopau i ka caffeine a hoʻonui i ka hopena o nā hopena ʻē aʻe e like me ka jitteriness, headache, hoʻonui i ka puʻuwai puʻuwai, a me nā hopena ʻē aʻe

ʻO Tiagabine (Gabitril)

Loaʻa ka caffeine iā Yerba mate. Lawe i ka caffeine ma kahi o kahi manawa me ka tiagabine hiki ke hoʻonui i ka nui o ka tiagabine i ke kino. Hoʻonui paha kēia i nā hopena a me nā hopena ʻaoʻao o ka tiagabine.

ʻO Ticlopidine (Ticlid)

Hōʻoki ke kino i ka caffeine ma yerba mate e kāpae iā ia. Hiki i ka Ticlopidine (Ticlid) ke hoʻēmi i ka wikiwiki e hoʻopau ke kino i ka caffeine. ʻO ka lawe ʻana i ka ipo yerba me ticlopidine e hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o ka caffeine, e like me ka jitteriness, hyperactivity, hoʻonāukiuki, a me nā mea ʻē aʻe.

ʻAlani ʻawahia

Mai hoʻohana i ka hoa kāne yerba me ka ʻalani ʻawaʻawa. Hoʻohui paha ka hui i ke kino, e hopena ai i ka piʻi ʻana o ke koko a me ka helu o ka puʻuwai, ʻoiai i ka poʻe me ke kaomi koko maʻamau.

Loaʻa nā mea kanu a me nā mea hoʻopili i ka cafe

Loaʻa ka caffeine iā Yerba mate. ʻO ka hoʻohana ʻana ia me nā mea kanu ʻē aʻe a i ʻole nā ​​mea hoʻopili i loko o ka caffeine paha e hoʻonui i ka hopena o nā hopena ʻē aʻe e pili ana i ka caffeine. ʻO nā huahana kūlohelohe ʻē aʻe i loko o ka caffeine e komo pū me ka koko, kope, cola nut, kī ʻeleʻele, tī oolong, a me ka guarana.

Kalipuna

Hoʻonui ka caffeine i ka hoa yerba e hoʻonui i ka hoʻopau ʻia ʻana o ke kino o ka puna. Inā hoʻohana ʻoe i ka nui o ka hoa yerba, e noi i kāu kauka inā he pono ʻoe e lawe i ka calcium hou aʻe e kōkua i ka hoʻopiha ʻana i ka calcium i nalowale i ka mimi.

Leialoha

Aia kekahi hopohopo i ka hui pū ʻana i ka caffeine, kahi kemikino i loaʻa i ka hoa wahine yerba, me ka ephedra a me ka creatine e hoʻonui ai i ka hopena o nā hopena olakino weliweli. ʻO kekahi mea haʻuki i lawe i 6 mau gram o ka monine monateate, 400-600 mg o ka caffeine, 40-60 mg o ka ephedra, a me nā ʻano pākuʻi ʻē aʻe i kēlā me kēia lā no 6 mau pule i loaʻa ka maʻi hahau. Hoʻoemi paha ka Caffeine i ka hiki i ka creatine ke hoʻomaikaʻi i ka hana pāʻani.

Ephedra (Ma huang)

Mai hoʻohana i ka hoa kāne yerba me ephedra. Hiki i kēia hui ʻana ke hoʻonui i ke kino a hoʻonui i ka makaʻu o ka hoʻoweliweli i ke ola a i ʻole ka hōʻeha ʻana i nā kūlana, e like me ke kiʻekiʻe o ke koko, ka puʻuwai, ka hahau ʻana, a me ka hopu ʻana Hiki i kēia hui pū ke kumu o ka make.

Nā mea kanu a me nā mea hoʻopihapiha e hoʻolohi i ke kō ʻana o ke koko

Hoʻolohi paha ʻo Yerba hoa i ke kāpili ʻana o ke koko. ʻO ka hoʻohana ʻana ia me nā mea kanu ʻē aʻe a i ʻole nā ​​mea hoʻopihapiha i loaʻa kēia hopena like e hoʻonui paha i ka makaʻi o ka palu a me ke kahe ʻana i kekahi poʻe. ʻO kekahi o kēia mau mea kanu e komo pū me angelica, clove, danshen, kālika, ginger, ginkgo, Panax ginseng, a me nā mea ʻē aʻe.

Makanekiuma

Loaʻa ka caffeine iā Yerba mate. E hoʻonui paha ka caffeine i ka wahine yerba i ka nui o ka magnesium i hoʻokuʻu ʻia i ka mimi.

ʻAʻole ʻike ʻia nā launa me nā meaʻai.

Aia ka mahele lāʻau kūpono o ka hoa i nā kumu like ʻole e like me ka makahiki o ka mea hoʻohana, olakino, a me nā ʻano ʻē aʻe. I kēia manawa ʻaʻole lawa ka ʻike ʻepekema e hoʻoholo ai i kahi pae kūpono o nā lāʻau no ka hoa. E hoʻomanaʻo i ka pono ʻole o ka palekana i nā huahana kūlohelohe a hiki i nā dosages ke koʻikoʻi. E mālama pono i nā ʻōkuhi pili i nā lepili huahana a nīnau i kāu kauka lāʻau a i ʻole kauka a i ʻole ʻoihana olakino ʻē aʻe ma mua o ka hoʻohana ʻana.

ʻO Chimarrao, Green Mate, Hervea, Ilex, Ilex paraguariensis, Jesuit's Brazil Tea, Teh Jesuit, Maté, Maté Folium, Paraguay Tea, St. Bartholemew's Tea, Thé de Saint Barthélémy, Thé des Jésuites, Thé du Brésil, Thé du Paraguay, Yerbamate , Yerba Mate, Yerba Maté.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. ʻO Gómez-Juaristi M, Martínez-López S, Sarria B, Bravo L, Mateos R. Hoʻomaʻamaʻa a me ka metabolism o yerba mate phenolic compound i loko o nā kānaka. Kemika Mea ʻai. 2018; 240: 1028-1038. Nānā kiʻi ʻole.
2. Chaves G, Britez N, Oviedo G, et al. ʻO nā mea inu nui o nā mea inu Ilex paraguariensis e hōʻike i nā hōʻike lipid haʻahaʻa akā ʻo ke kaumaha o ke kino kiʻekiʻe. ʻO Phytother Res. 2018; 32: 1030-1038. Nānā kiʻi ʻole.
3. Wikoff D, Welsh BT, Henderson R, et al. ʻO ka loiloi ʻōnaehana o nā hopena maikaʻi ʻole o ka ʻai ʻana o ka caffeine i nā mākua olakino, nā wahine hāpai, nā ʻōpio, a me nā keiki. Nā Mea Hana Meaola Toxicol 2017; 109: 585-648. Nānā kiʻi ʻole.
4. ʻO Voskoboinik A, Kalman JM, Kistler PM. Caffeine a me arrhythmia: manawa e wili ai i ka ʻikepili. JACC: ʻOihana Electrophysiol. 2018; 4: 425-32.
5. Lagier D, Nee L, Guieu R, et al. ʻAʻole hiki i ka ca-caine waha waha ke pale i ka fibrillation atrial ma hope o ke kī ʻana o ka puʻuwai puʻuwai me ka bypass cardiopulmonary: kahi hoʻokolohua hoʻokolohua hoʻokolohua kaulike ʻia. Eur J Anaesthesiol. 2018 Apr 26. [Epub ma mua o ka paʻi] Nānā i ka abstract.
6. Souza SJ, Petrilli AA, Teixeira AM, et al. Ka hopena o ke kokoleka a me ka tiita mate ma ka hōʻike lipid o kēlā me kēia kanaka me ka maʻi HIV / AIDS ma ka antiretroviral therapy: kahi hoʻokolohua hoʻokolohua. Meaʻai kūpono. 2017 Nov-Dec; 43-44: 61-68. Nānā kiʻi ʻole.
7. ʻO Areta JL, Austarheim I, Wangensteen H, Capelli C. Metabolic a me nā hopena hana o yerba mate ma nā mea holo kaʻa hoʻomaʻamaʻa aʻo maikaʻi. Hoʻolālā Med Med Sports. 2017 Nov 7. Nānā i ka abstract.
8. Jung J-H, Hur Y-I. Ka hopena o ka hopena o ka hoa ma ke kaupaona o ke kino a me ka hoʻemi momona i nā wahine momona: kahi hoʻokolohua hoʻokolohua hoʻokolohua hoʻokolohua placebo. Kōlea J OBes. 2016; 25: 197-206.
9. Alkhatib A, Atcheson R. Yerba Mate (Ilex paraguariensis) metabolic, satiety, a me ke ʻano o ke ʻano i ka hoʻomaha a me ka hoʻolōʻihi hoʻolōʻihi. Nutrients. 2017 Aug 15; 9. Pii: E882. Nānā kiʻi ʻole.
10. da veiga DTA, Bringhenti R, Bolignon AA, et al. Loaʻa ka hopena kūlike ʻole o ka yerba mate ʻai i ka iwi: kahi hoʻopaʻa hihia ʻana i nā wahine postmenopausal. ʻO Phytother Res. 2018 Ian; 32: 58-64. Nānā kiʻi ʻole.
11. Zuchinali P, Riberio PA, Pimentel M, da Rosa PR, Zimerman LI, Rohde LE. Ka hopena o ka caffeine ma ka ventricular arrhythmia: kahi ʻōnaehana loiloi a me nā meta-analysis o nā hoʻokolohua hoʻokolohua a me nā hoʻokolohua. Europace 2016 Pepelu; 18: 257-66. Nānā kiʻi ʻole.
12. International Agency for Research on Cancer (IARC). Loiloi nā monarona IARC i ka inu kope, hoa kāne, a me nā mea inu wela loa. https://www.iarc.fr/en/media-centre/pr/2016/pdfs/pr244_E.pdf. Loaʻa iā Nowemapa 1, 2017.
13. Kim SY, Oh MR, Kim MG, Chae HJ, Chae SW. Nā hopena anti-obesity o yerba mate (Ilex Paraguariensis): kahi hoʻokolohua hoʻokolohua hoʻokolohua kaulua ʻia, pālua makapō. Hoʻohui ʻo BMC Altern Med. 2015; 15: 338. Nānā kiʻi ʻole.
14. Yu S, Yue SW, Liu Z, Zhang T, Xiang N, Fu H. Yerba mate (Ilex paraguariensis) hoʻomaikaʻi i ka microcirculation o nā mea manawaleʻa me ka viscosity kiʻekiʻe o ke koko: kahi hoʻokolohua hoʻokolohua, makapō makapō, kahi placebo-kāohi ʻia. Exp Gerontol. 2015; 62: 14-22. Nānā kiʻi ʻole.
15. Stefani ED, Moore M, Aune D, Deneo-Pellegrini H, Ronco AL, Boffetta P, et al. ʻO ka ʻai a Maté a me ka makaʻu o ka maʻi ʻaʻai: kahi noiʻi hihia-maha hihia maha-ma Uruguay. ʻO Asian Pac J Ka maʻi ʻaʻai Prev. 2011; 12: 1089-93. Nānā kiʻi ʻole.
16. ʻO Gambero A a me Ribeiro ML. Nā hopena maikaʻi o yerba mate (Ilex paraguariensis) i ka momona. Nutrients. 2015; 7: 730-50. Nānā kiʻi ʻole.
17. Dixit S, Stein PK, Dewland TA, Dukes JW, Vittinghoff E, Heckbert SR, Marcus GM. Kaʻai ʻana i nā huahana Caffeinated a me Cardiac Ectopy. ʻO J Am Heart Assoc. 2016 26; 5. pii: e002503. hana: 10.1161 / JAHA.115.002503. Nānā kiʻi ʻole.
18. ʻO Cheng M, Hu Z, Lu X, Huang J, Gu D. Caffeine ka lawe ʻana a me ka hanana atrial fibrillation: pane pane meta-ʻanalike o nā noi cohort prospective. Hiki iā J Cardiol. 2014 ʻApela; 30: 448-54. hana: 10.1016 / j.cjca.2013.12.026. Epub 2014 2. Loiloi. Nānā kiʻi ʻole.
19. ʻO Caldeira D, Martins C, Alves LB, Pereira H, Ferreira JJ, Costa J. Caffeine ʻaʻole e hoʻonui i ka makaʻu o ka atrial fibrillation: kahi loiloi ʻōnaehana a me nā meta-analysis o nā noiʻi nānā. Puʻuwai. 2013; 99: 1383-9. hana: 10.1136 / heartjnl-2013-303950. Loiloi. Nānā kiʻi ʻole.
20. Meyer, K. a me Ball, P. Psychological a me Cardiovascular hopena o Guarana a me Yerba Mate: kahi hoʻohālikelike me ka kope. Revista Interamericana de Psicologia 2004; 38: 87-94.
21. Klein, GA, Stefanuto, A., Boaventura, BC, de Morais, EC, Cavalcante, Lda S., de, Andrade F., Wazlawik, E., Di Pietro, PF, Maraschin, M., a me da Silva, EL Hoʻomaikaʻi ke kī inu Mate (Ilex paraguariensis) i nā glycemic a me nā lipid profiles o ka maʻi diabetes type 2 a me nā kānaka pre-diabetes: kahi noiʻi pailaka. ʻO J Am Coll.Nutr. 2011; 30: 320-332. Nānā kiʻi ʻole.
22. Hussein, G. M., Matsuda, H., Nakamura, S., Akiyama, T., Tamura, K., a me Yoshikawa, M. Nā pale a me nā hopena ameliorative o ka hoa (Ilex paraguariensis) i ka maʻi metabolic i nāʻiole TSOD. Phytomedicine. 12-15-2011; 19: 88-97. Nānā kiʻi ʻole.
23. de Morais, EC, Stefanuto, A., Klein, GA, Boaventura, BC, de, Andrade F., Wazlawik, E., Di Pietro, PF, Maraschin, M., a me da Silva, EL Hoʻohana o yerba mate (Ilex paraguariensis) hoʻomaikaʻi i nā palena lipid serum i nā kumuhana dislipidemic olakino a hāʻawi i kahi hōʻemi LDL-kolesterol hou i kēlā me kēia kanaka ma statin therapy. J Agric. ʻO Kemika ʻAi. 9-23-2009; 57: 8316-8324. Nānā kiʻi ʻole.
24. ʻO Martins, F., Noso, TM, Porto, VB, Curiel, A., Gambero, A., Bastos, DH, Ribeiro, ML, a me Carvalho, Pde O. Mate kī ke kāpae i ka vitro pancreatic lipase activity a he hypolipidemic hopena ma ʻiole momona momona. Kaona. (Kālā. Puna) 2010; 18: 42-47. Nānā kiʻi ʻole.
25. Arcari, DP, Bartchewsky, W., dos Santos, TW, Oliveira, KA, Funck, A., Pedrazzoli, J., de Souza, MF, Saad, MJ, Bastos, DH, Gambero, A., Carvalho, Pde O ., a me Ribeiro, ML Nā hopena Antiobesity o ka yerba mate extract (Ilex paraguariensis) i nāʻiole momona momona. Kaona. (Kālā. Puna) 2009; 17: 2127-2133. Nānā kiʻi ʻole.
26. Sugimoto, S., Nakamura, S., Yamamoto, S., Yamashita, C., Oda, Y., Matsuda, H., a me Yoshikawa, M. Nā lāʻau kūlohelohe Brazil. III. nā hanana o nā triterpene oligoglycosides a me nā mea hoʻopuka lipase mai ka hoa, nā lau o ka ilex paraguariensis. ʻO Chem.Pharm.Bull. (Tokyo) 2009; 57: 257-261. Nānā kiʻi ʻole.
27. ʻO Matsumoto, RL, Bastos, DH, Mendonca, S., Nunes, VS, ʻo Bartchewsky, W., Ribeiro, ML, a me de Oliveira, ʻo Carvalho P. Nā hopena o ka tiʻi hoa (Ilex paraguariensis) e hoʻopili ana i ka mRNA hōʻike o nā antioxidant enzymes, lipid peroxidation, a me ka huina kūlana antioxidant i nā wahine ʻōpio olakino. J Agric. ʻO Kemika ʻAi. 3-11-2009; 57: 1775-1780. Nānā kiʻi ʻole.
28. ʻO Pang, J., Choi, Y., a me Park, T. Ilex paraguariensis e lawe i nā ameliorates momona i hoʻokomo ʻia e ka momona momona momona: ka hana kūpono o AMPK i ka aʻa visceral adipose kiko. Arch.Biochem.Biophys. 8-15-2008; 476: 178-185. Nānā kiʻi ʻole.
29. ʻO Miranda, DD, Arcari, DP, Pedrazzoli, J., Jr., Carvalho, Pde O., Cerutti, SM, Bastos, DH, a me Ribeiro, ML Nā hopena pale o ka ti ti (Ilex paraguariensis) ma ka H2O2-i hoʻokomo ʻia i nā pōʻino a me Hoʻoponopono DNA i nāʻiole. ʻO Mutagenesis 2008; 23: 261-265. Nānā kiʻi ʻole.
30. Milioli, EM, Cologni, P., Santos, CC, Marcos, TD, Yunes, VM, Fernandes, MS, Schoenfelder, T., a me Costa-Campos, L. Ka hopena o ka lawelawe nui ʻana o ka wai waiʻona o Ilex paraguariensis St Hilaire ( Aquifoliaceae) i nā hiʻohiʻona holoholona o ka maʻi o Parkinson. Phytother.Res 2007; 21: 771-776. Nānā kiʻi ʻole.
31. Martin, I., Lopez-Vilchez, M. A., Mur, A., Garcia-Algar, O., Rossi, S., Marchei, E., a me Pichini, S. Neonatal withdrawal syndrome ma hope o ka inu mau ʻana o ka makuahine o ka hoa. ʻO Ther Monit Monit. 2007; 29: 127-129. Nānā kiʻi ʻole.
32. Mosimann, A. L., Wilhelm-Filho, D., a me da Silva, E. L. Aqueous extract o Ilex paraguariensis hoʻoliʻiliʻi i ka holomua o ka atherosclerosis i nā lāpaki hānai kolesterol. Nā Biofactors 2006; 26: 59-70. Nānā kiʻi ʻole.
33. Gorzalczany, S., Filip, R., Alonso, M. R., Mino, J., Ferraro, G. E., a me Acevedo, C. Choleretic hopena a me nā ʻōpū o ka 'mate' (Ilex paraguariensis) a me kāna mau mea pani a moe kolohe paha. ʻO J Ethnopharmacol. 2001; 75 (2-3): 291-294. Nānā kiʻi ʻole.
34. Fonseca, C. A., Otto, S. S., Paumgartten, F. J., a me Leitao, A. C. Nontoxic, mutagenic, a me nā hana clastogenic o Mate-Chimarrao (Ilex paraguariensis). J.En environment.Pathol.Toxicol.Oncol. 2000; 19: 333-346. Nānā kiʻi ʻole.
35. ʻO Martinet, A., Hostettmann, K., a me Schutz, Y. Nā hopena Thermogenic o ka hoʻomākaukau mea kanu i loaʻa no ka mālama ʻana i ka momona o kānaka. Phytomedicine. 1999; 6: 231-238. Nānā kiʻi ʻole.
36. ʻO Pittler, M. H., Schmidt, K., a me Ernst, E. Nā hanana maikaʻi ʻole o nā mea hoʻopili meaʻai no ka hoʻoliʻiliʻi kaumaha o ke kino: loiloi ʻōnaehana. ʻO Obes.Rev. 2005; 6: 93-111. Nānā kiʻi ʻole.
37. ʻO Pittler, M. H. a me Ernst, E. Nā mea kōkua meaʻai no ka hoʻoliʻiliʻi kaumaha o ke kino: kahi loiloi ʻōnaehana. Am.J.Clin Nutr. 2004; 79: 529-536. Nānā kiʻi ʻole.
38. ʻO Dickel, M. L., Nā Lākiō, S. M., a me Ritter, M. R. ʻO nā mea kanu i hoʻohana nui ʻia no ka wehe ʻana i nā kumu kaumaha ma Porto Alegre, Brazil Hema. ʻO J Ethnopharmacol 1-3-2007; 109: 60-71. Nānā kiʻi ʻole.
39. ʻO Fotherby, M. D., Ghandi, C., Haigh, R. A., Macdonald, T. A., a me Potter, J. F. ʻAʻohe o ka hopena o ka hoʻohana ʻana i ka caffeine i ka poʻe ʻelemakule. Cardiology i ka poʻe kūpuna 1994; 2: 499-503.
40. Jeppesen, U., Loft, S., Poulsen, H. E., a me Brsen, K. A fluvoxamine-caffeine interaksi hoʻopaʻa. Pharmacogenetics 1996; 6: 213-222. Nānā kiʻi ʻole.
41. ʻO Smits, P., Lenders, J. W., a me Thien, T. Caffeine a me theophylline e hoʻouluulu i ka vasodilation adenosine i loko o ke kanaka. ʻO Clin.Pharmacol.Ther. 1990; 48: 410-418. Nānā kiʻi ʻole.
42. Gronroos, N. N. a me Alonso, A. ʻAi a me ka makaʻu o ka atrial fibrillation - epidemiologic a me nā hōʻike maʻi. Circ. J 2010; 74: 2029-2038. Nānā kiʻi ʻole.
43. ʻO Clausen, T. Hormonal a me ka hoʻololi ʻana o ka lāʻau o ka homeostasis potassium plasma. Fundam.Clin Pharmacol 2010; 24: 595-605. Nānā kiʻi ʻole.
44. Reis, J. P., Loria, C. M., Steffen, L. M., Zhou, X., van, Horn L., Siscovick, D. S., Jacobs, D.R., Jr., a me Carr, J. J. Kope, kope decaffeined, caffeine, a me ke kī inu i ka wā ʻōpio a me atherosclerosis ma hope o ke ola: ke aʻo CARDIA. Arterioscler. Thomb. Vasc.Biol 2010; 30: 2059-2066. Nānā kiʻi ʻole.
45. ʻO Bracesco, N., Sanchez, A. G., Contreras, V., Menini, T., a me Gugliucci, A. Nā hana hou e pili ana i ka noiʻi Ilex paraguariensis: Minireview. ʻO J Ethnopharmacol. 6-26-2010; Nānā kiʻi ʻole.
46. Conen, D., Chiuve, S. E., Everett, B. M., Zhang, S. M., Buring, J. E., a me Albert, C. M. Caffeine ʻai a me nā hanana atrial fibrillation i nā wahine. ʻO Am J Clin Nutr 2010; 92: 509-514. Nānā kiʻi ʻole.
47. Ernest, D., Chia, M., a me Corallo, C. E. hypokalaemia hohonu ma muli o Nurofen Plus a me Red Bull hoʻohana hewa. Hoʻomaha Resitc Crit. 2010; 12: 109-110. Nānā kiʻi ʻole.
48. ʻO Rigato, I., Blarasin, L., a me Kette, F. hypokalemia loa i nā mea holo paikikala ʻelua ma muli o ka lawe nui ʻana o ka caffeine. ʻO Clin J Sport Med. 2010; 20: 128-130. Nānā kiʻi ʻole.
49. ʻO Simmonds, M. J., Minahan, C. L., a me Sabapathy, S. Caffeine e hoʻomaikaʻi i ke kaʻa uila supramaximal akā ʻaʻole ka helu o ka hoʻokuʻu ikehu anaerobic. Eur.J Appl Physiol 2010; 109: 287-295. Nānā kiʻi ʻole.
50. Zhang, W., Lopez-Garcia, E., Li, T. Y., Hu, F. B., a me van Dam, R. M. Kaʻai ʻana i ka kofe a me ka makaʻu ʻana i nā maʻi maʻi maʻi puʻuwai a me nā mea make āpau i waena o nā kāne me ka maʻi diabetes type 2. Mālama Diabetes 2009; 32: 1043-1045. Nānā kiʻi ʻole.
51. Lopez-Garcia, E., Rodriguez-Artalejo, F., Rexrode, K. M., Logroscino, G., Hu, F. B., a me van Dam, R. M. Kaʻai ʻana i ka kofe a me ka makaʻu o ka hahau ʻana i nā wahine. Kaapuni 3-3-2009; 119: 1116-1123. Nānā kiʻi ʻole.
52. Smits, P., Temme, L., a me Thien, T. ʻO ka laulima cardiovascular ma waena o ka caffeine a me ka nikotine i loko o nā kānaka. ʻO Clin Pharmacol Ther 1993; 54: 194-204. Nānā kiʻi ʻole.
53. ROTH, J. L. Loiloi loiloi i ka hoʻokolokolo ʻana o ka caffeine gastric i nā mea maʻi maʻi maʻi duodenal. ʻO Gastroenterology 1951; 19: 199-215. Nānā kiʻi ʻole.
54. ʻO Joeres R, Richter E. Mexiletine a me ka hoʻopau caffeine. N Engl J Med 1987; 317: 117. Nānā kiʻi ʻole.
55. Zelenitsky SA, Norman A, Nix DE. Nā hopena o ka fluconazole ma luna o nā pharmacokinetics o ka caffeine i nā kumuhana ʻōpio a me nā ʻelemākule. ʻO J Infect Dis Pharmacother 1995; 1: 1-11.
56. Mattila MJ, Vainio P, Nurminen ML, et al. Midazolam 12 mg e hoʻopaneʻe ʻia e ka caffeine 250 mg i ke kāne. Int J Clin Pharmacol Ther 2000; 38: 581-7. Nānā kiʻi ʻole.
57. ʻO Mattila ME, ʻo Mattila MJ, ʻo Nuotto E. Caffeine e hoʻohālikelike i nā hopena o triazolam a me zopiclone ma ka hana psychomotor o nā kumuhana olakino. ʻO Pharmacol Toxicol 1992; 70: 286-9. Nānā kiʻi ʻole.
58. ʻO Mattila MJ, Nuotto E. Caffeine a me nā hopena theophylline counteract diazepam i ke kāne. Med Biol 1983; 61: 337-43. Nānā kiʻi ʻole.
59. ʻO Mattila MJ, Palva E, Savolainen K. Caffeine antagonize nā hopena diazepam i ke kāne. Med Biol 1982; 60: 121-3. Nānā kiʻi ʻole.
60. File SE, Bond AJ, Lister RG. Ka launa ma waena o nā hopena o ka caffeine a me lorazepam i nā hoʻokolohua hana a me nā helu ponoʻī. ʻO J Clin Psychopharmacol 1982; 2: 102-6. Nānā kiʻi ʻole.
61. ʻO Broughton LJ, ʻo Rogers HJ. Hoʻoemi i ka ʻae ʻana o ka caffeine ma muli o ka cimetidine. ʻO Br J Clin Pharmacol 1981; 12: 155-9. Nānā kiʻi ʻole.
62. Azcona O, Barbanoi MJ, Torrent J, Jane F. Ka loiloi i nā hopena waena o ka waiʻona a me ka caaffine. Br J Clin Pharmacol 1995; 40: 393-400. Nānā kiʻi ʻole.
63. Norager, C. B., Jensen, M. B., Weimann, A., a me Madsen, M. R. Nā hopena Metabolic o ka ʻai ʻana i ka caffeine a me ka hana kino i nā kamaʻāina he 75 mau makahiki. A randomized, pālua makapō, placebo-kaohi, keʻa aʻo. ʻO Clin Endocrinol (Oxf) 2006; 65: 223-228. Nānā kiʻi ʻole.
64. ʻO Mays, D. C., Camisa, C., Cheney, P., Pacula, C. M., Nawoot, S., a me Gerber, ʻo N. Methoxsalen kahi mea kāohi i ka metabolism o ka caffeine i loko o nā kānaka. ʻO Clin.Pharmacol.Ther. 1987; 42: 621-626. Nānā kiʻi ʻole.
65. ʻO Mohiuddin, M., Azam, A. T., Amran, M. S., a me Hossain, M. A. I nā hopena vive o ka gliclazide a me ka metformin i ka hoʻonui plasma o ka caffeine i nā ʻiole olakino. Pak.J Biol Sci 5-1-2009; 12: 734-737. Nānā kiʻi ʻole.
66. ʻO Gasior, M., Swiader, M., Przybylko, M., Borowicz, K., Turski, WA, Kleinrok, Z., a me Czuczwar, SJ Felbamate e hōʻike nei i ka haʻahaʻa haʻahaʻa no ka launa pū ʻana me methylxanthines a me Ca2 + mau modulator e kūʻē i ka hopu ʻana i ka iʻa i nāʻiole. . Eur.J Pharmacol 7-10-1998; 352 (2-3): 207-214. Nānā kiʻi ʻole.
67. ʻO Vaz, J., Kulkarni, C., David, J., a me Joseph, T. Ka hopena o ka caffeine ma ka hopena o ka pharmacokinetic o ka sodium valproate a me ka carbamazepine i nā manawaleʻa kanaka maʻamau. ʻO India J.Exp.Biol. 1998; 36: 112-114. Nānā kiʻi ʻole.
68. ʻO Chroscinska-Krawczyk, M., Jargiello-Baszak, M., Walek, M., Tylus, B., a me Czuczwar, S. J. Caffeine a me ka ikaika anticonvulsant o nā lāʻau antiepileptic: ʻike hoʻokolohua a me ka maʻi. ʻO Pharmacol. Rep. 2011; 63: 12-18. Nānā kiʻi ʻole.
69. ʻO Luszczki, J. J., Zuchora, M., Sawicka, K. M., Kozinska, J., a me Czuczwar, ʻo S. J. ʻO ka ʻike nui ʻana i ka caffeine e hoʻemi ana i ka hana anticonvulsant o ka ethosuximide, akā ʻaʻole ka clonazepam, phenobarbital a me valproate e kūʻē i ka hopu ʻana o pentetrazole i nāʻiole. Repubalika Pharmacol. 2006; 58: 652-659. Nānā kiʻi ʻole.
70. Jankiewicz, K., Chroscinska-Krawczyk, M., Blaszczyk, B., a me Czuczwar, S. J. [Caffeine a me nā lāʻau antiepileptic: nā hōʻike hoʻokolohua a me nā ʻike maʻi]. Przegl.Lek. 2007; 64: 965-967. Nānā kiʻi ʻole.
71. ʻO Gasior, M., Borowicz, K., Buszewicz, G., Kleinrok, Z., a me Czuczwar, S. J. Anticonvulsant hana o phenobarbital a me valproate e pili ana i ka electroshock maximal i nāʻiole i ka wā o ka mālama mau ʻana me ka caffeine a me ka hoʻopau ʻana o ka caffeine. Epilepsia 1996; 37: 262-268. Nānā kiʻi ʻole.
72. ʻO Kot, M. a me Daniel, W. A. ​​Ka hopena o diethyldithiocarbamate (DDC) a me ticlopidine ma ka hana CYP1A2 a me ka caffeine metabolism: kahi noiʻi hoʻohālikelike in vitro me CYP1A2 i hōʻike ʻia cDNA kanaka a me nā microsome ate. Repubalika Pharmacol. 2009; 61: 1216-1220. Nānā kiʻi ʻole.
73. Fuhr, U., Strobl, G., Manaut, F., Anders, EM, Sorgel, F., Lopez-de-Brinas, E., Chu, DT, Pernet, AG, Mahr, G., Sanz, F. , a. Nā ʻākena antibacterial Quinolone: ​​ka pilina ma waena o ka hanana a me ka in vitro inhibition o ka cytochrome P450 kanaka isoform CYP1A2. Mol.Pharmacol. 1993; 43: 191-199. Nānā kiʻi ʻole.
74. ʻO Stille, W., Harder, S., Mieke, S., Beer, C., Shah, P. M., Frech, K., a me Staib, A. H. Ka hoʻemi ʻana i ka hoʻopau caffeine i loko o ke kanaka i ka wā o ke alakaʻi ʻana o 4-quinolones. J. ʻAntimicrob. Luna 1987; 20: 729-734. Nānā kiʻi ʻole.
75. Staib, A. H., Stille, W., Dietlein, G., Shah, P. M., Harder, S., Mieke, S., a me Beer, C. Ka launa pū ma waena o ka quinolones a me ka caffeine. Nā lāʻau 1987; 34 Hōʻuluʻulu 1: 170-174. Nānā kiʻi ʻole.
76. Shet, M. S., McPhaul, M., Fisher, C. W., Stallings, N. R., a me Estabrook, R. W. Metabolism o ka lāʻau antiandrogenic (Flutamide) na CYP1A2 kanaka. ʻO ka hoʻolei ʻana o ka Metab Lapaʻau. 1997; 25: 1298-1303. Nānā kiʻi ʻole.
77. Kynast-Gales SA, Massey LK. Ka hopena o ka caffeine ma ka excretion o ka urinary calcium a me ka magnesium. ʻO J Am Coll Nutr. 1994; 13: 467-72. Nānā kiʻi ʻole.
78. Ochiai R, Jokura H, Suzuki A, et al. Hoʻomaikaʻi ke kope pīni Green i ka vasoreactivity kanaka. ʻO Hypertens Res 2004; 27: 731-7. Nānā kiʻi ʻole.
79. ʻO Conforti AS, ʻo Gallo ME, ʻo Saraví FD. ʻO ka meaʻai ʻo Yerba Mate (Ilex paraguariensis) e pili ana me ka kiʻekiʻe o ka mineral o ka iwi i nā wahine postmenopausal. Bone 2012; 50: 9-13. Nānā kiʻi ʻole.
80. Robinson LE, Savani S, Battram DS, et al. ʻO ka ʻai ʻana i ka caffeine ma mua o ka hoʻāʻo ʻana o ka glucose glucose waha e hoʻopōʻino ai i ka mālama ʻana i ka glucose koko i nā kāne me ka maʻi diabetes type 2. ʻO J Nutr 2004; 134: 2528-33. Nānā kiʻi ʻole.
81. Lake CR, Rosenberg DB, Gallant S, et al. Hoʻonui ka Phenylpropanolamine i ka pae o ka caffeine plasma. ʻO Clin Pharmacol Ther 1990; 47: 675-85. Nānā kiʻi ʻole.
82. Forrest WH Jr, Bellville JW, Brown BW Jr. ʻO ka launa pū ʻana o ka caffeine me pentobarbital ma ke ʻano he hypnotic i ka pō. Anesthesiology 1972; 36: 37-41. Nānā kiʻi ʻole.
83. Raaska K, Raitasuo V, Laitila J, Neuvonen PJ. Ka hopena o ka caffeine-i loaʻa me ka kofe decaffeinated ma nā concum clozapine serum i nā mea maʻi maʻi. Nānā Haumāna Pharmacol Toxicol 2004; 94: 13-8. Nānā kiʻi ʻole.
84. Watson JM, Sherwin RS, Deary IJ, et al. Hoʻokaʻawale ʻia o nā physiological augmented, hormonal a me nā noʻonoʻo noʻonoʻo i ka hypoglycaemia me ka hoʻohana ʻana i ka caffeine. ʻO Clin Sci (Lond) 2003; 104: 447-54. Nānā kiʻi ʻole.
85. ʻO Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. ʻO ka lawe ʻana i ka caffeine maʻamau a me ka makaʻu o ke kiʻekiʻe i nā wahine. JAMA 2005; 294: 2330-5. Nānā kiʻi ʻole.
86. ʻO Juliano LM, ʻo Griffiths RR. He loiloi koʻikoʻi no ka haʻalele ʻana o ka caffeine: ka hōʻoia empirical o nā ʻōuli a me nā hōʻailona, ​​nā hanana, ka paʻakikī, a me nā hiʻohiʻona e pili ana. Psychopharmacology (Berl) 2004; 176: 1-29. Nānā kiʻi ʻole.
87. Leson CL, McGuigan MA, Bryson SM. ʻO ka overdose caffeine i kahi kāne ʻōpio. ʻO J Toxicol Clin Toxicol 1988; 26: 407-15. Nānā kiʻi ʻole.
88. Benowitz NL, Osterloh J, Goldschlager N, a me al. Hoʻokuʻu ʻia ka catecholamine nui mai ka lāʻau ʻino caffeine. ʻO JAMA 1982; 248: 1097-8. Nānā kiʻi ʻole.
89. Acheson KJ, Gremaud G, Meirim I, et al. Nā hopena Metabolic o ka caffeine i loko o nā kānaka: oxidation lipid a i ʻole paikikala makehewa paha? 'Am J Clin Nutr 2004; 79: 40-6. Nānā kiʻi ʻole.
90. Haller CA, Benowitz NL, Jacob P 3. Nā hopena Hemodynamic o ephedra-free weight-loss supplement i loko o kānaka. Am J Med 2005; 118: 998-1003 .. Nānā i ka abstract.
91. Santos IS, Matijasevich A, Valle NC. E inu ana i ka wahine i ka wā hāpai a me ka makaʻu o ka preterm a liʻiliʻi no ka hānau hānau. ʻO J Nutr 2005; 135: 1120-3. Nānā kiʻi ʻole.
92. Petrie HJ, Chown SE, Belfie LM, et al. Hoʻonui ka ʻai ʻana i ka caffeine i ka pane o ka insulin i ka hoʻāʻo oral-glucose-tolerance i nā kāne momona ma mua a ma hope o ka pohō kaumaha. ʻO Am J Clin Nutr 2004; 80: 22-8. Nānā kiʻi ʻole.
93. Lane JD, Barkauskas CE, Surwit RS, Feinglos MN. Hoʻopilikia ka caffeine i ka glucose glucose i ka maʻi diabetes type 2. Nānā Diabetes 2004; 27: 2047-8. Nānā kiʻi ʻole.
94. ʻO Saldana MD, Zetzl C, ʻo Mohamed RS, ʻo Brunner G. Extraction o nā methylxanthines mai nā huaʻa guarana, nā lau hoa, a me nā pī niʻu koko e hoʻohana ana i ka carbon dioxide supercritical a me ka etanol. ʻO J Agric Food Chem 2002; 50: 4820-6. Nānā kiʻi ʻole.
95. Andersen T, Fogh J. Ka emi ʻana o ke kaumaha a hoʻolohi i ka haʻalele ʻana o ka gastric ma hope o kahi hoʻomākaukau lāʻau lapaʻau ʻAmelika Hema i nā mea maʻi kaumaha. ʻO J Hum Nutr Diet 2001; 14: 243-50. Nānā kiʻi ʻole.
96. Esmelindro AA, Girardi Jdos S, Mossi A, et al. Ka hopena o nā loli agronomic ma ka hoʻohui ʻana o nā lau kī mate (Ilex paraguariensis) nā mea i lawe ʻia mai ka lawe ʻana mai CO2 ma 30 degrees C a me 175 bar. ʻO J Agric Food Chem 2004; 52: 1990-5. Nānā kiʻi ʻole.
97. Sewram V, De Stefani E, Brennan P, Boffetta P. Mate ʻai a me ka makaʻu o ka squamous cell esophageal cancer i uruguay. Nā maʻi maʻi Epidemiol Biomarkers Prev 2003; 12: 508-13. Nānā kiʻi ʻole.
98. ʻO Goldenberg D, Golz A, Joachims HZ. ʻO ka hoa inu mea inu: kahi pilikia no ka maʻi ʻaʻai o ke poʻo a me ka ʻāʻī. Head Neck 2003; 25: 595-601. Nānā kiʻi ʻole.
99. Cannon ME, Cooke CT, McCarthy JS. ʻO ka arrhythmia cardiac i hoʻokomo ʻia e ka caffeine: kahi makaʻu ʻike ʻole ʻia o nā huahana meaʻai. Med J Aust 2001; 174: 520-1. Nānā kiʻi ʻole.
100. ʻO KL Durrant. ʻIke ʻia a hūnā ʻia nā kumu lāʻau i loko o ka lāʻau, ka meaʻai, a me nā huahana kūlohelohe. ʻO J Am Pharm Assoc 2002; 42: 625-37. Nānā kiʻi ʻole.
101. Dews PB, O'Brien CP, Bergman J. Caffeine: nā hopena lawena o ka haʻalele a me nā pilikia e pili ana. Meaʻai Chem Toxicol 2002; 40: 1257-61. Nānā kiʻi ʻole.
102. Holmgren P, Norden-Pettersson L, Ahlner J. Caffeine mau mea make - ʻehā mau hōʻike hihia. Forensic Sci Int 2004; 139: 71-3. Nānā kiʻi ʻole.
103. ʻO Chou T. E ala a honi i ke kope. Caffeine, kope, a me nā hopena olakino. West J Med 1992; 157: 544-53. Nānā kiʻi ʻole.
104. Howell LL, Coffin VL, Spealman RD. Nā hopena a me nā hopena physiological o xanthines i nā primates nonhuman. Psychopharmacology (Berl) 1997; 129: 1-14. Nānā kiʻi ʻole.
105. Ke Kula Lapaʻau. ʻO Caffeine no ke Kākoʻo o ka Hana ʻana i ka Manaʻo Mental: Formulated for Military Operations. Wakinekona, DC: National Academy Press, 2001. Loaʻa ma: http://books.nap.edu/books/0309082587/html/index.html.
106. Zheng XM, Williams RC. Nā pae caffeine serum ma hope o ka pau ʻana o 24 mau hola: nā hopena maʻi ma ka dipyridamole Tl myocardial perfusion kiʻi. ʻO J Nucl Med Technol 2002; 30: 123-7. Nānā kiʻi ʻole.
107. Aqel RA, Zoghbi GJ, Trimm JR, et al. Ka hopena o ka caffeine lawelawe intravenously ma intracoronary-lawelawe ʻia adenosine-hoʻokomo ʻia hemodynamics coronary i nā mea maʻi me ka maʻi coronary artery. 'Am J Cardiol 2004; 93: 343-6. Nānā kiʻi ʻole.
108. ʻO Underwood DA. ʻO nā lāʻau hea pono e mālama ʻia ma mua o kahi kaukōloa a i ʻole hoʻāʻo koʻikoʻi koʻikoʻi? ʻO Cleve Clin J Med 2002; 69: 449-50. Nānā kiʻi ʻole.
109. Smith A. Nā hopena o ka caffeine i ka lawena kanaka. Meaʻai Chem Toxicol 2002; 40: 1243-55. Nānā kiʻi ʻole.
110. ʻO Stanek EJ, Melko GP, Charland SL. ʻO ka hana Xanthine me ka dipyridamole-thallium-201 kiʻi myocardial. ʻO ka lāʻau lapaʻau 1995; 29: 425-7. Nānā kiʻi ʻole.
111. ʻO Carrillo JA, Benitez J. ʻO nā hana pharmacokinetic koʻikoʻi ma waena o ka caffeine dietary a me nā lāʻau. ʻO Clin Pharmacokinet 2000; 39: 127-53. Nānā kiʻi ʻole.
112. ʻO Wahllander A, Paumgartner G. Ka hopena o ketoconazole a me terbinafine ma nā pharmacokinetics o ka caffeine i nā mea manawaleʻa olakino. Eur J Clin Pharmacol 1989; 37: 279-83. Nānā kiʻi ʻole.
113. ʻO Sanderink GJ, Bournique B, Stevens J, et al. Ka hoʻokomo ʻana i ka isoenzymes CYP1A kanaka i loko o ka metabolism a me nā launa lāʻau o riluzole i vitro. ʻO Pharmacol Exp Ther 1997; 282: 1465-72. Nānā kiʻi ʻole.
114. ʻO Brown NJ, Ryder D, lālā RA. ʻO ka launa lāʻau pharmacodynamic ma waena o ka caffeine a me phenylpropanolamine. ʻO Clin Pharmacol Ther 1991; 50: 363-71. Nānā kiʻi ʻole.
115. ʻO Abernethy DR, Todd EL. Ka hōʻino ʻia o ka ʻae ʻana i ka caffeine ma o ka hoʻohana mau ʻana o ka estrogen low-dose estrogen-i loaʻa i nā contraceptive waha. Eur J Clin Pharmacol 1985; 28: 425-8. Nānā kiʻi ʻole.
116. Mei DC, Jarboe CH, VanBakel AB, Williams WM. Nā hopena o ka cimetidine ma ke ʻano caffeine i nā mea puhipaka a me nā mea ʻume ʻole. ʻO Clin Pharmacol Ther 1982; 31: 656-61. Nānā kiʻi ʻole.
117. Nawrot P, Jordan S, Eastwood J, et al. Nā hopena o ka caffeine i ke olakino kanaka. Hoʻohui Hoʻohui Hoʻohui 2003; 20: 1-30. Nānā kiʻi ʻole.
118. Massey LK, Whiting SJ. Caffeine, urinary calcium, calcium metabolism a me ka iwi. ʻO J Nutr 1993; 123: 1611-4. Nānā kiʻi ʻole.
119. Infante S, Baeza ML, Calvo M, et al. ʻO Anaphylaxis ma muli o ka caffeine. Allergy 2003; 58: 681-2. Nānā kiʻi ʻole.
120. Nix D, Zelenitsky S, Symonds W, et al. ʻO ka hopena o fluconazole ma nā lāʻau lapaʻau lāʻau o ka caffeine i nā kumuhana ʻōpio a me nā ʻelemākule. ʻO Clin Pharmacol Ther 1992; 51: 183.
121. Kockler DR, McCarthy MW, Lawson CL. Ka hopu ʻana i ka hana a me ka pane ʻole ʻana ma hope o kaʻai ʻana o hydroxycut. Pharmacotherapy 2001; 21: 647-51 .. Nānā i ka abstract.
122. Grandjean AC, Reimers KJ, Bannick KE, Haven MC. ʻO ka hopena o nā caffeine, ʻole caffeine, inu a me nā mea inu ʻole calorie i ka hydration. ʻO J Am Coll Nutr 2000; 19: 591-600 .. Nānā i ka abstract.
123. ʻO Dreher HM. ʻO ka hopena o ka hoʻemi ʻana o ka caffeine i ka maikaʻi o ka hiamoe a me ke olakino maikaʻi i nā kānaka me ka maʻi HIV. J Psychosom Res 2003; 54: 191-8 .. Nānā i ka abstract.
124. Massey LK. ʻO ka caffeine kahi pilikia no ka nalo ʻana o ka iwi i ka poʻe kahiko? ʻO Am J Clin Nutr 2001; 74: 569-70. Nānā kiʻi ʻole.
125. ʻO McGowan JD, Altman RE, Kanto WP Jr Neonatal haʻalele i nā ʻōuli ma hope o ka lawe mau ʻana o ka caffeine i ka makuahine. Hema Med J 1988; 81: 1092-4 .. Nānā i ka abstract.
126. ʻO Bara AI, Barley EA. Caffeine no ka hānō. ʻO Cochrane Database Syst Rev 2001; 4: CD001112 .. Nānā i ka abstract.
127. ʻO Horner NK, Lampe JW. ʻO nā ʻano hana kūpono o ka hoʻoponopono papaʻai no nā kūlana umauma fibrocystic hōʻike i ka lawa ʻole o ka hōʻike. ʻO J Am Diet Assoc 2000; 100: 1368-80. Nānā kiʻi ʻole.
128. ʻO Bell DG, ʻo Jacobs I, ʻo Ellerington K. Ka hopena o ka caffeine a me ka hoʻopili ʻana i ka ephedrine ma ka hana hoʻoikaika anaerobic. Med Sci Sports Exerc 2001; 33: 1399-403. Nānā kiʻi ʻole.
129. Avisar R, Avisar E, Weinberger D. Ka hopena o ka ʻai kope ma ke kaomi intraocular. Ann Pharmacother 2002; 36: 992-5 .. Nānā i ka abstract.
130. ʻO Ferrini RL, ʻo Barrett-Connor E. Kaʻai caffeine a me nā pae steroid endogenous sex steroid i nā wahine postmenopausal. ʻO ka Rancho Bernardo Study. Am J Epidemiol 1996: 144: 642-4. Nānā kiʻi ʻole.
131. ʻO Ardlie NG, Glew G, Schultz BG, Schwartz CJ. Ka pāpā a me ka hoʻohuli hou ʻana o ka hōʻiliʻili platelet e methyl xanthines. ʻO Thromb Diath Haemorrh 1967; 18: 670-3. Nānā kiʻi ʻole.
132. Ali M, Afzal M. He mea kāohi i ka thrombin stimulate platelet thromboxane hoʻokumu ʻia mai ka tī kī ʻole ʻia. Prostaglandins Leukot Med 1987; 27: 9-13. Nānā kiʻi ʻole.
133. Haller CA, Benowitz NL. ʻO nā hanana ʻōnaehana cardiovascular a me nā ʻōnaehana kikowaena e pili ana i nā mea hoʻopihapihaʻai piha me nā alkaloids ephedra. N Engl J Med 2000; 343: 1833-8. Nānā kiʻi ʻole.
134. ʻO Sinclair CJ, Geiger JD. Hoʻohana ka cafe i nā haʻuki. ʻO kahi loiloi lāʻau. ʻO J Sports Med Phys Fitness 2000; 40: 71-9. Nānā kiʻi ʻole.
135. ʻAmelika Hui Pū ʻIa o Pediatrics. ʻO ka hoʻolilo ʻia ʻana o nā lāʻau a me nā kemika ʻē aʻe i ka waiū kanaka. Nā Pediatrics 2001; 108: 776-89. Nānā kiʻi ʻole.
136. Lloyd T, Johnson-Rollings N, Eggli DF, et al. ʻO ke kūlana iwi ma waena o nā wahine postmenopausal me nā ʻano like ʻole o ka loaʻa ʻana o ka caffeine: kahi hoʻokolokolo lōʻihi. ʻO J Am Coll Nutr 2000; 19: 256-61. Nānā kiʻi ʻole.
137. Watson JM, Jenkins EJ, Hamilton P, et al. Ka hopena o ka caffeine ma ke alapine a me ka ʻike o ka hypoglycemia i nā mea maʻi ola me ka maʻi diabetes 1. Mālama Diabetes 2000; 23: 455-9. Nānā kiʻi ʻole.
138. ʻO Fetrow CW, ʻo Avila JR. ʻO ka puke lima ʻoihana ʻoihana o nā lāʻau laulima a me nā lāʻau lapaʻau ʻē aʻe. 1st ed. ʻO Springhouse, PA: Springhouse Corp., 1999.
139. ʻO McGee J, Patrick RS, Wood CB, Blumgart LH. ʻO kahi hihia o ka maʻi veno-occlusive o ke akepaʻa ma Pelekane e pili ana me ka ʻai ʻana i nā lāʻau ulu. ʻO J Clin Pathol 1976; 29: 788-94. Nānā kiʻi ʻole.
140. Hagg S, Spigset O, Mjorndal T, Dahlqvist R. Ka hopena o ka caffeine ma ka clozapine pharmacokinetics i nā mea manawaleʻa olakino. Br J Clin Pharmacol 2000; 49: 59-63. Nānā kiʻi ʻole.
141. Williams MH, lālā JD. Hoʻokumu ka Creatine a me ka hana hoʻoikaika kino: kahi hoʻohou. ʻO J Am Coll Nutr 1998; 17: 216-34. Nānā kiʻi ʻole.
142. ʻO FDA. Kuhi i manaʻo ʻia: nā mea hoʻopihapiha papaʻai i loko o nā alkaloid ephedrine. Loaʻa ma: www.verity.fda.gov (Loaʻa iā 25 Ianuali 2000).
143. Dews PB, Curtis GL, Hanford KJ, O'Brien CP. ʻO ke alapine o ka haʻalele ʻana o ka caffeine i kahi ana lehulehu a me kahi hoʻokolohua hoʻokolohua hoʻomalu makapō ʻia. ʻO J Clin Pharmacol 1999; 39: 1221-32. Nānā kiʻi ʻole.
144. Nurminen ML, Niittynen L, Korpela R, Vapaatalo H. Kope, caffeine a me ke kahe koko: he loiloi koʻikoʻi. Eur J Clin Nutr 1999; 53: 831-9. Nānā kiʻi ʻole.
145. DiPiro JT, Talbert RL, Yee GC, et al; nā ʻaoʻao Pharmacotherapy: kahi ala pathophysiologic. ʻEhā ed. Stamford, CT: Appleton & Lange, 1999.
146. Pollock BG, Wylie M, Stack JA, et al. Ka pāpā ʻana o ka caffeine metabolism e ka estrogen replacement therapy i nā wahine postmenopausal. ʻO J Clin Pharmacol 1999; 39: 936-40. Nānā kiʻi ʻole.
147. Wemple RD, Keikialii DR, McKeever KH. ʻO nā mea inu haʻuki ʻole Caffeine vs caffeine: nā hopena ma ka mimi hana i ka hoʻomaha a me ka hoʻolōʻihi hoʻolōʻihi. Int J Sports Med 1997; 18: 40-6. Nānā kiʻi ʻole.
148. Stookey JD. Nā hopena diuretic o ka waiʻona a me ka caffeine a me ka helu piha ʻana i ka wai. Eur J Epidemiol 1999; 15: 181-8. Nānā kiʻi ʻole.
149. ʻO Fernandes O, Sabharwal M, Smiley T, et al.Kahi kūpono i ka ʻai nui ʻana o ka caffeine i ka wā hāpai a me ka pilina i ka ʻōpū kūlohelohe a me ka ulu fetal maʻamau: kahi meta-analysis. Reprod Toxicol 1998; 12: 435-44. Nānā kiʻi ʻole.
150. Klebanoff MA, Levine RJ, DerSimonian R, et al. ʻO ka paraxanthine serum makuahine, kahi metabolite caffeine, a me ka makaʻu o ka hāpai wale ʻana o ka manawa. N Engl J Med 1999; 341: 1639-44. Nānā kiʻi ʻole.
151. ʻO ka Polokalamu Toxicology National (NTP). Kāpena Ke kikowaena no ka loiloi i nā pilikia i ka hana hou ʻana o ke kanaka (CERHR). Loaʻa ma: http://cerhr.niehs.nih.gov/common/caffeine.html.
152. Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Hoʻonui ka lawe ʻana i ka caffeine i ka helu o ka nalo ʻana o ka iwi i nā wahine ʻelemākule a me nā launa pū ʻana me nā genotypes reseptor vitamin D. ʻO Am J Clin Nutr 2001; 74: 694-700. Nānā kiʻi ʻole.
153. Chiu KM. Ka hopena o nā mea hoʻopiha calcium ma ka iwi i nā wahine postmenopausal. ʻO J Gerontol A Biol Sci Med Sci 1999; 54: M275-80. Nānā kiʻi ʻole.
154. Vandeberghe K, Gillis N, Van Leemputte M, et al. Kākoʻo Caffeine i ka hana ergogenic o ka hoʻoulu ʻana i ka musine. ʻO J Appl Physiol 1996; 80: 452-7. Nānā kiʻi ʻole.
155. Wallach J. Ka wehewehe ʻana i nā hōʻike hōʻoia. ʻO kahi synopsis o Laboratory Medicine. Fifth ed; Boston, MA: Little Brown, 1992.
156. De Stefani E, Fierro L, Correa P, et al. ʻO ka inu inu a me ka makaʻu o ka maʻi ʻaʻa maʻi i nā kāne: kahi hoʻopaʻa ʻana i ka hihia mai Uruguay. ʻO nā maʻi maʻi maʻi Epidemiol Biomarkers Prev 1996; 5: 515-9. Nānā kiʻi ʻole.
157. De Stefani E, Correa P, Fierro L, et al. Paka ʻeleʻele, hoa, a me ka maʻi ʻaʻai pūhū. Ke aʻo ʻana i ka hihia hihia mai Uruguay. Kanesa 1991; 67: 536-40. Nānā kiʻi ʻole.
158. De Stefani E, Fierro L, Mendilaharsu M, et al. ʻO ka lawe ʻana i ka ʻiʻo, ka inu 'hoa' a me ka maʻi ʻaʻai pūpū ma Uruguay: kahi hoʻokolokolo. ʻO Br J Cancer 1998; 78: 1239-43. Nānā kiʻi ʻole.
159. Pintos J, Franco EL, Oliveira BV, et al. ʻO Mate, kope, a me nā mea inu tī a me ka makaʻu o nā maʻi ʻino o ka wahi aerodigestive luna ma ka hema o Brazil. Epidemiology 1994; 5: 583-90. Nānā kiʻi ʻole.
160. Hodgson JM, Puddey IB, Burke V, et al. Nā hopena i ke kaomi koko o ka inu ʻana i ka tī ʻōmaʻomaʻo a me ka ʻeleʻele. ʻO J Hypertens 1999; 17: 457-63. Nānā kiʻi ʻole.
161. Wakabayashi K, Kono S, Shinchi K, et al. ʻO ka ʻai ʻana o ka kofe maʻamau a me ke kahe o ke koko: Ke aʻo ʻana i nā luna hoʻomalu pale iā Iapana. Eur J Epidemiol 1998; 14: 669-73. Nānā kiʻi ʻole.
162. No Dieter, Ma kahi kokoke i ka Loss Hope loa. Ka Wakinekona Wakinekona. Loaʻa ma: http://www.washingtonpost.com/archive/politics/2000/03/19/for-dieter-nearly-the-ultimate-loss/c0f07474-489d-4f44-bc17-1f1367c956ae/ (Loaʻa iā 19 Malaki 2000 ).
163. Vahedi K, Domingo V, Amarenco P, Bousser MG. ʻO ka hahau Ischemic i loko o kahi haʻuki nāna i hoʻopau i ka MaHuang extract a hana i ka monesterolate no ke bodybuilding. ʻO J Neurol Neurosurg Psychiatr 2000; 68: 112-3. Nānā kiʻi ʻole.
164. ʻO Joeres R, Klinker H, Heusler H, et al. Ka hopena o ka mexiletine ma ka hoʻopau ʻana i ka caffeine. ʻO Pharmacol Ther 1987; 33: 163-9. Nānā kiʻi ʻole.
165. Hsu CK, Leo P, Shastry D, et al. ʻO ka lāʻau make Anticholinergic e pili ana i nā tī kī. Arch Intern Med 1995; 155: 2245-8. Nānā kiʻi ʻole.
166. Healy DP, Polk RE, Kanawati L, et al. Ka launa ma waena o ciprofloxacin oral a me caffeine i nā mea manawaleʻa maʻamau. Nā Antimicrob Agents Chemother 1989; 33: 474-8. Nānā kiʻi ʻole.
167. Carbo M, Segura J, De la Torre R, et al. Ka hopena o nā quinolones ma ka caffeine disposition. ʻO Clin Pharmacol Ther 1989; 45: 234-40. Nānā kiʻi ʻole.
168. Harder S, Fuhr U, Staib AH, Wolff T. Ciprofloxacin-caffeine: kahi launa lāʻau i hoʻokumu ʻia me ka hoʻohana ʻana i ka vivo a me nā noiʻi in vitro. 'Am J Med 1989; 87: 89S-91S. Nānā kiʻi ʻole.
169. Morris JC, Beeley L, Ballantine N. Ka launa pū ʻana o ka ethinyloestradiol me ka ascorbic acid i loko o ke kāne [leka]. Br Med J (Clin Res Ed) 1981; 283: 503. Nānā kiʻi ʻole.
170. ʻO Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis e kūʻē i ka diarrhea pili i ka ampicillin me kahi hoʻomākaukau lactobacillus. ʻO Am J Hosp Pharm 1979; 36: 754-7. Nānā kiʻi ʻole.
171. ʻO Shearer MJ, Bach A, Kohlmeier M. Chemistry, nā kumuwaiwai, ka hāʻawi ʻana i nā aʻa a me ka metabolism o ka huaola K me ke kuhikuhi kūikawā i ka olakino iwi. ʻO J Nutr 1996; 126: 1181S-6S. Nānā kiʻi ʻole.
172. ʻO McEvoy GK, hoʻoponopono. ʻO ka ʻike ʻo AHFS Ka lāʻau. Bethesda, MD: ʻAmelika Hui Pū ʻIa o Health-System Pharmacists, 1998.
173. ʻO ka loiloi o nā huahana kūlohelohe e nā ʻoiaʻiʻo a me nā hoʻohālikelike. Louis, MO: Wolters Kluwer Co., 1999.
174. Blumenthal M, ed. ʻO ke Komikina Kelemania E Monographs: Alakaʻi Therapeutic i nā lāʻau Laʻau. Trans. S. Klein. ʻO Boston, MA: ʻAmelika Botanical Council, 1998.

Nānā hope - 06/04/2019